<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01220791</url>
  </required_header>
  <id_info>
    <org_study_id>Medrol005</org_study_id>
    <nct_id>NCT01220791</nct_id>
  </id_info>
  <brief_title>Methylprednisolone Addition in IVF Treatment of Infertile Couples</brief_title>
  <official_title>Methylprednisolone vs. Placebo to Control Late Follicular Progesterone Elevation in GnRH-Antagonist IVF Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioGenesis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>HRG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently
      control late follicular progesterone rise during IVF treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim is to investigate any potential advantages of adding cortisone supplementation from
      the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo
      quality and pregnancy outcome.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progesterone rise above 1.5ng.ml on the day of HCG</measure>
    <time_frame>up to 14 days of follicular ovarian stimulation</time_frame>
    <description>Incidence or high progesterone on the day of HCG triggering</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>Follow pregnancy until delivery</time_frame>
    <description>Success rate in IVF cycles</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>In Vitro Fertilization</condition>
  <arm_group>
    <arm_group_label>Follicular Medrol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In an Antagonist protocol for IVF patients will also receive 4mg tabl. Methylprednisolone twice a day from the day 2 of ovarian stimulation and until the day of the pregnancy test on luteal day-14 post oocyte retrieval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No medrol group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive only Antagonist protocol for IVF as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In vitro fertilization treatment for infertility</intervention_name>
    <description>IVF treatment</description>
    <arm_group_label>Follicular Medrol</arm_group_label>
    <arm_group_label>No medrol group</arm_group_label>
    <other_name>pregnancy</other_name>
    <other_name>MEDROL</other_name>
    <other_name>progesterone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  less than 36, more than 10 antral follicles, FSH&lt;12

        Exclusion Criteria:

          -  endometriosis stage III&amp;IV,
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Basil Tarlatzis, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>BioGenesis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evangelos Papanikolaou, MD</last_name>
    <phone>0030 2310 424284</phone>
    <email>drvagpapanikolaou@yahoo.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Biogenesis</name>
      <address>
        <city>Thessaloniki</city>
        <state>Pylaia</state>
        <zip>55536</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evangelos Papanikolaou, MD,PhD</last_name>
      <phone>0030 2310 989160</phone>
      <email>drvagpapanikolaou@yahoo.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <link>
    <url>http://www.hrg.gr</url>
    <description>web page of investigator centre</description>
  </link>
  <reference>
    <citation>Bider D, Menashe Y, Goldenberg M, Dulitzky M, Lifshitz A, Dor J. Dexamethasone as an adjuvant therapy for anovulatory, normoandrogenic patients during ovulation induction with exogenous gonadotropins. J Assist Reprod Genet. 1996 Sep;13(8):613-6.</citation>
    <PMID>8897119</PMID>
  </reference>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2010</study_first_submitted>
  <study_first_submitted_qc>October 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2010</study_first_posted>
  <last_update_submitted>October 13, 2010</last_update_submitted>
  <last_update_submitted_qc>October 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Papanikolaou Evangelos</name_title>
    <organization>HRG</organization>
  </responsible_party>
  <keyword>methylprednisolone</keyword>
  <keyword>IVF</keyword>
  <keyword>progesterone</keyword>
  <keyword>corticosteroid</keyword>
  <keyword>late follicular phase</keyword>
  <keyword>pregnancy rates</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

